Fidelity growth partners will be investing in Cipla's newest division, consumer healthcare, which is aimed at pushing the sale of the pharma major's over the counter drugs. CNBC-TV18 spoke to Chandru Chawla, the head of Cipla, New Ventures, about the valuation of the consumer healthcare market in India.Calling consumer healthcare to be an exciting space for the company, he says: "Consumer health market in India is upwards of USD 4 billion today and is growing at a very high double digit."Hopeful about the growth in this market, he adds: "We expect to see that in certain consumer categories, the consumer health spends will be three to four times of the low digit consumer spends that we see in those categories."
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
